Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.

    Access Status
    Fulltext not available
    Authors
    Chikh, A.
    Ferro, R.
    Abbott, J.
    Piñeiro, R.
    Buus, R.
    Iezzi, M.
    Ricci, F.
    Bergamaschi, D.
    Ostano, P.
    Chiorino, G.
    Lattanzio, R.
    Broggini, M.
    Piantelli, M.
    Maffucci, T.
    Falasca, Marco
    Date
    2016
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Chikh, A. and Ferro, R. and Abbott, J. and Piñeiro, R. and Buus, R. and Iezzi, M. and Ricci, F. et al. 2016. Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression. Oncotarget. 7 (14): pp. 18325-18345.
    Source Title
    Oncotarget
    DOI
    10.18632/oncotarget.7761
    School
    School of Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/32599
    Collection
    • Curtin Research Publications
    Abstract

    It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical trials. Although eight distinct PI3K isoforms exist, grouped into three classes, most of the evidence currently available are focused on one specific isoform with very little known about the potential role of the other members of this family in cancer. Here we demonstrate that the class II enzyme PI3K-C2β is overexpressed in several human breast cancer cell lines and in human breast cancer specimens. Our data indicate that PI3K-C2β regulates breast cancer cell growth in vitro and in vivo and that PI3K-C2β expression in breast tissues is correlated with the proliferative status of the tumor. Specifically we show that downregulation of PI3K-C2β in breast cancer cell lines reduces colony formation, induces cell cycle arrest and inhibits tumor growth, in particular in an estrogen-dependent in vivo xenograft. Investigation of the mechanism of the PI3K-C2β-dependent regulation of cell cycle progression and cell growth revealed that PI3K-C2β regulates cyclin B1 protein levels through modulation of microRNA miR-449a levels. Our data further demonstrate that downregulation of PI3K-C2β inhibits breast cancer cell invasion in vitro and breast cancer metastasis in vivo. Consistent with this, PI3K-C2β is highly expressed in lymph-nodes metastases compared to matching primary tumors. These data demonstrate that PI3K-C2β plays a pivotal role in breast cancer progression and in metastasis development. Our data indicate that PI3K-C2β may represent a key molecular switch that regulates a rate-limiting step in breast tumor progression and therefore it may be targeted to limit breast cancer spread.

    Related items

    Showing items related by title, author, creator and subject.

    • Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
      Falasca, Marco; Maffucci, T. (2014)
      Phosphoinositide 3-kinases (PI3Ks) regulate several cellular functions that are critical for cancer progression and development, including cell survival, proliferation and migration. Three classes of PI3Ks exist with the ...
    • Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
      Falasca, Marco; Maffucci, T. (2014)
      Phosphoinositide 3-kinases (PI3Ks) regulate several cellular functions that are critical for cancer progression and development, including cell survival, proliferation and migration. Three classes of PI3Ks exist with the ...
    • Manganese Superoxide Dismutase Expression Regulates the Switch between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma
      Loo, S.; Hirpara, J.; Pandey, V.; Tan, T.; Yap, C.; Lobie, P.; Thiery, J.; Goh, B.; Pervaiz, Shazib; Clément, M.; Kumar, Alan Prem (2016)
      Aim: Epithelial-mesenchymal transition (EMT) is characterized by the acquisition of invasive fibroblast-like morphology by epithelial cells that are highly polarized. EMT is recognized as a crucial mechanism in cancer ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.